I think that patient number 862 was for end of quarter. Probably an average closer to 800 I’d expect might be better in the calculation.
That would then be approximately $95,000/patient/quarter and translate to between 1000-1200 patients averaging across the period to hit guidance. Obviously lower in q2 and growing through the year.
- Forums
- ASX - By Stock
- Acadia
I think that patient number 862 was for end of quarter. Probably...
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.07 |
Change
-0.320(1.65%) |
Mkt cap ! $2.440B |
Open | High | Low | Value | Volume |
$19.55 | $19.65 | $18.88 | $1.903M | 99.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 66 | $19.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.07 | 94 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 161 | 19.060 |
8 | 374 | 19.050 |
5 | 484 | 19.040 |
7 | 422 | 19.030 |
5 | 1353 | 19.020 |
Price($) | Vol. | No. |
---|---|---|
19.090 | 222 | 7 |
19.100 | 629 | 13 |
19.110 | 334 | 4 |
19.120 | 756 | 4 |
19.130 | 364 | 4 |
Last trade - 10.52am 31/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online